Shopping Cart
Remove All
Your shopping cart is currently empty
Benufutamab (GEN1029) is an agonistic antibody targeting death receptor 5 (DR5) with anti-tumor activity, used in the study of solid tumors.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $328 | In Stock | In Stock | |
| 5 mg | $993 | In Stock | In Stock | |
| 10 mg | $1,590 | - | In Stock | |
| 25 mg | $2,360 | - | In Stock | |
| 50 mg | $3,180 | - | In Stock |
| Description | Benufutamab (GEN1029) is an agonistic antibody targeting death receptor 5 (DR5) with anti-tumor activity, used in the study of solid tumors. |
| In vitro | Benufutamab (20 μg/mL, 24h) induced cytotoxicity in primary multiple myeloma (MM) cells with a median cell killing rate of 36%. [1] |
| In vivo | The antitumor activity of Benufutamab (0.5 mg/ kg-10 mg/kg, intravenously administered once a week) was confirmed in models of colorectal, pancreatic, gastric, NSCLC, and melanoma cell lines, showing significant antitumor activity. |
| Synonyms | Hx-DR5-05, Hx-DR5-01, GEN1029, GEN 1029 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Cas No. | 2109730-69-8 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.